CORE Kidney

Current Trials

Ongoing Trials

Anifrolumab (NCT05138133) - Lupus Nephritis 

https://clinicaltrials.gov/study/NCT05138133?term=NCT05138133&rank=1

Sponsor: AstraZeneca

Phase: 3 

Accrual Status: Recruiting

 

Rayulizumab (NCT04564339) - Lupus Nephritis

https://clinicaltrials.gov/study/NCT04564339?term=NCT04564339&rank=1

Sponsor: Alexion Pharmaceuticals, Inc. 

Phase: 2

Accrual Status: Active, not recruiting

 

Rayulizumab (NCT06291376) - IgA Nephropathy

https://clinicaltrials.gov/study/NCT06291376?term=NCT06291376&rank=1

Sponsor: Alexion Pharmaceuticals, Inc.

Phase: 3

Accrual Status: Recruiting

 

Atacicept (NCT04716231) - IgA Nephropathy

https://clinicaltrials.gov/study/NCT04716231?term=NCT04716231&rank=1

Sponsor: Vera Therapeutics, Inc.

Phase: 3

Accrual Status: Recruiting

 

Sefaxersen (NCT05797610) - IgA Nephropathy

https://clinicaltrials.gov/study/NCT05797610?term=NCT05797610&rank=1

Sponsor: Hoffman-La Roche

Phase 3:

Accrual Status: Pending open to accrual

 

Iptacopan (NCT04578834) - IgA Nephropathy

https://clinicaltrials.gov/study/NCT04578834?term=NCT04578834&rank=1

Sponsor: Novartis Pharmaceuticals

Phase: 3

Accrual Status: Active, not recruiting

 

DISC-0974 (NCT05745883) - CKD

https://clinicaltrials.gov/study/NCT05745883?term=NCT05745883&rank=1

Sponsor: Disc Medicine, Inc.

Phase: 1b

Accrual Status: Recruiting

 

Finerenone (NCT05047263) - CKD

https://clinicaltrials.gov/study/NCT05047263?term=NCT05047263&rank=1

Sponsor: Bayer

Phase: 3

Accrual Status: Active, not recruiting

 

Vonafexor (NCT06425055) - Alport Syndrome

https://clinicaltrials.gov/study/NCT06425055?term=NCT06425055&rank=1

Sponsor: Enyo Pharma

Phase: Proof-of-concept study

Accrual Status: Active, not recruiting

 

Prismocitrate 18 (NCT05399537) - Renal Replacement Therapy

https://clinicaltrials.gov/study/NCT05399537?term=NCT05399537&rank=1

Sponsor: Baxter

Phase: 3

Accrual Status: Pending open to accrual

 

Observational Program (NCT00196742) - Fabry

https://clinicaltrials.gov/study/NCT00196742?term=NCT00196742&rank=1

Sponsor: Genzyme, a Sanofi company

Phase: Registry

Accrual Status: Recruiting

 

HM15421/GC1134A - Fabry

Sponsor: Hanmi Pharmaceutical Co. LTF., GC Biopharma Corp

Phase 1/2

Accrual Status: Pending open to accrual

 

Venglustat (NCT05280548) - Fabry

https://clinicaltrials.gov/study/NCT05280548?term=NCT05280548&rank=1

Sponsor: Sanofi

Phase: 3

Accrual Status: Active, not recruiting

 

FabrazymE (NCT06019728) - Fabry

https://clinicaltrials.gov/study/NCT06019728?term=NCT06019728&rank=1

Sponsor: Sanofi

Phase: 4

Accrual Status: Active, not recruiting

 

Venglustat (NCT05206773) - Fabry

https://clinicaltrials.gov/study/NCT05206773?term=NCT05206773&rank=1

Sponsor: Sanofi

Phase: 3

Accrual Status: Active, not recruiting

 

Repagermanium (NCT05183646) - FSGS

https://clinicaltrials.gov/study/NCT05183646?term=NCT05183646&rank=1

Sponsor: Dimerix Bioscience Pty Ltd

Phase: 3

Accrual Status: Pending open to accrual

 

ABBV-CLS-628 - ADPKD

Sponsor: Abbvie

Phase: 2

Accrual Status: Pending open to accrual